last modified：2024/04/11
Professor YONEDA Takashi
Faculty, Affiliation
Faculty of Transdisciplinary Sciences, Institute of Philosophy in Interdisciplinary Sciences
College and School Educational Field
Division of Medical Sciences, Graduate School of Medical Science
Division of Medicine, Graduate School of Medical Science
Faculty of Global Standard Education, Institute of Liberal Arts and Science
School of Medicine, College of Medical, Pharmaceutical and Health Sciences
Department of Laboratory Sciences，School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences
School of Entrepreneurial and Innovation Studies, College of Transdisciplinary Sciences for Innovation
Laboratory
Department of Health Promotion and Medicine of the Future, Kanazawa University TEL:076-265-2778 FAX:076-234-4251
Academic Background
【Academic background(Doctoral/Master's Degree)】
Kanazawa University Doctor Graduate School, Division of Medicine 1994 Completed
【Academic background(Bachelor's Degree)】
Kanazawa University 199003
Career
Kanazawa University(1999/04/01-)
Year & Month of Birth
Academic Society
The Endocrine Society
Japan Diabetes Society
Award
Specialities
Endocrinology、Hypertension、Endocrinology、Metabolomics、Cardiovascular medicine、Medical sociology
Speciality Keywords
Endocrinology, Hypertension, Medical Innovation, Reguratory Science, Telemedicine,Health Promotion
Research Themes
Study on Pathogenesis of Endocrine tumor
Hypertension, Cardiovascular Endocrinology
Medical Innovation
Books
Papers
- Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome. Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo T, Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group. Eur J Endocrinol. 182 3 265-273 2020/03
- Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling. Aono D, Kometani M, Karashima S, Usukura M, Gondo Y, Hashimoto A, Demura M, Furukawa K, Takeda Y, Kawashiri M, Yoneda T Hypertens Res. 42 12 1942-1950 2019/12
- Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia. Kometani M, Yoneda T, Demura M, Aono D, Gondoh Y, Karashima S, Nishimoto K, Yasuda M, Horike SI, Takeda Y. Steroids. 151 108470 2019/11
- Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes. Sawada K, Karashima S, Kometani M, Oka R, Takeda Y, Sawamura T, Fujimoto A, Demura M, Wakayama A, Usukura M, Yagi K, Takeda Y, Yoneda T. Endocr J. 2018/04
- Study Protocol for the Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on Glycemic Control in Patients with Type 2 Diabetes Mellitus. Oka R, Nomura A, Yasugi A, Kometani M, Gondoh Y, Yoshimura K, Yoneda T. Diabetes Ther. 10 3 1151-1161 2019/06
- The status of glycemic control and hypoglycemia in elderly patients visiting the outpatient department specializing in diabetes. Soma Y, Oka R, Fujii S, Ito N, Kometani M, Karashima S, Takeda Y, Yoneda T, Asano A. Nihon Ronen Igakkai Zasshi. 2018/05
- Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism. Wada N, Shibayama Y, Yoneda T, Naruse M その他15名 JPAS/JRAS Study Group. J Endocr Soc. 16 3 1393-1402 2019/05
- Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index. Aono D, Oka R, Kometani M, Takeda Y, Karashima S, Yoshimura K, Takeda Y, Yoneda T. J Diabetes Res. 2018/03
- High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan. Akehi Y, Yanase T,Yoneda T, Naruse M; その他37名 Japan Primary Aldosteronism Study Group. Diabetes Care 42 5 938-945 2019/05
- Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism. Kometani M, Yoneda T, Aono D, Karashima S, Demura M, Nishimoto K, Yamagishi M, Takeda Y. Oncotarget. 2018/05
- Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Naruse M; その他20名 JPAS Study Group. J Hypertens. 37 5 1077-1082 2019/05
- Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism. Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M. J Endocr Soc. 2018/05
- C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study. Ohbatake A, Yagi K, Karashima S, Shima Y, Miyamoto Y, Asaka H, Okazaki S, Kometani M, Kawashiri MA, Takeda Y, Yoneda T, Chujo D. Diabetes Ther. 10 2 673-681 2019/04
- Severe Mitral Regurgitation As a Result of Rupture of Mitral Valve Chordae Tendineae in a Patient With Graves Disease. Karashima S, Tsuda T, Kometani M, Oka R, Demura M, Kawashiri MA, Takeda Y, Hayashi K, Yoneda T. J Endocr Soc. 2018/09
- Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function. Kobayashi H, Abe M, Yoneda T, Naruse M; その他22名 JPAS/JRAS Study Group. Hypertension. 74 3 630-638 2020/01
- Associations between Sleep-Disordered Breathing and Metabolic Risk Factors beyond Obesity. Wakabayashi Y, Oka R, Nakaya M, Karashima S, Kometani M, Sakurai M, Yoshimura K, Yoneda T. J Diabetes Res. 2018/10
- Madelung disease in a 58-year-old man. Karashima S, Yoneda T. CMAJ. 2019/01
- The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism. Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T. J Endocr Soc 2018/05
- Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II. Takeda Y, Demura M, Wang F, Karashima S, Yoneda T, Kometani M, Hashimoto A, Aono D, Horike SI, Meguro-Horike M, Yamagishi M, Takeda Y. J Am Heart Assoc. 2018/05
- Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index. Aono D, Oka R, Kometani M, Takeda Y, Karashima S, Yoshimura K, Takeda Y, Yoneda T. J Diabetes Res. 2018/05
- The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism. Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T. J Endocr Soc. 2 5 398-407 2018/03
- Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study. Karashima S, Kometani M, Tsujiguchi H, Asakura H, Nakano S, Usukura M, Mori S, Ohe M, Sawamura T, Okuda R, Hara A, Takamura T, Yamagishi M, Nakamura H, Takeda Y, Yoneda T. Clin Exp Hypertens. 40 2 118-125 2018/03
- Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group. Hypertension 71 3 530-537 2018/03
- Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community. Tada H, Kawashiri MA, Sakata K, Yoneda T, Yasuda K, Yamagishi M, Hayashi K. Atherosclerosis. 261 111-116. 2017/06
- Trajectories of Postload Plasma Glucose in the Development of Type 2 Diabetes in Japanese Adults. Oka R, Shibata K, Sakurai M, Kometani M, Yamagishi M, Yoshimura K, Yoneda T. J Diabetes Res. 5307523. 2017
- Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia. Kometani M, Yoneda T, Demura M, Koide H, Nishimoto K, Mukai K, Gomez-Sanchez CE, Akagi T, Yokota T, Horike SI, Karashima S, Miyamori I, Yamagishi M, Takeda Y. Sci Rep. ７ １ 11205 2017/09/11
- Ventricular Fibrillation Associated With Dynamic Changes in J-Point Elevation in a Patient With Silent Thyroiditis. Karashima S, Tsuda T, Wakabayashi Y, Kometani M, Demura M, Ichise T, Kawashiri MA, Takeda Y, Hayashi K, Yoneda T. J Endocr Soc. ２ ２ 135-139. 2017/12/06
- Reply to Kawada: One-hour plasma glucose as a predictor of Type 2 diabetes mellitus. Oka R, Aizawa T, Yoneda T, Yamagishi M. Diabet Med. 34 5 734. 2017
- Unilateral Primary Aldosteronism with Spontaneous Remission after Long-Term Spironolactone Therapy. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2012/02
- Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats. DIABETES OBESITY & METABOLISM 14 2 155-162 2012/02
- Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. HYPERTENSION RESEARCH 34 1 98-102 2011/01
- Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats. J Hypertens. 19 7 635-639 2001/03
- Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues. J Hypertens. 29 6 1185-95 2011/06
- Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma. STEROIDS 76 12 1363-6 2011/11
- Cardiac aldosterone production in genetically hypertensive rats. Hypertension. 36 10 495-500 2000/10
- Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation. 105 6 677-679 2002/02
- Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. HUMAN MUTATION 19 1 23-29 2002/01
- Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency. Clin Endocrinol 54 6 751-758 2001/06
- Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology. 141 5 1901-1904 2000/05
- Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension. Hypertension. 30 4 953-956 1997/10
- Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study. Sawamura T, Karashima S, Ohbatake A, Higashitani T, Ohmori A, Sawada K, Yamamoto R, Kometani M, Katsuda Y, Yoneda T. Medicina 2024/03
- Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation. Nakano E, Mukai K, Fukuhara A, Otsuki M, Shimomura I, Ichijo T, Tsuiki M, Wada N, Yoneda T, Takeda Y, Oki K, Yamada T, Ogawa Y, Yabe D, Kakutani M, Sone M, Katabami T, Tanabe A, Naruse M; JPAS/JRAS Study Group. Endocr J. 2024/03
- Violaceous abdominal striae noted on physical examination: a clue to the diagnosis of Cushing's syndrome. Sawamura T, Kometani M, Karashima S, Yoneda T. BMJ Case Rep. 2024/03
- Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism. Takeda Y, Demura M, Kometani M, Karashima S, Aono D, Konishi S, Horike SI, Meguro-Horike M, Yoneda T, Takeda Y. Endocr J. 2024/03
- Thyrotoxicosis Misdiagnosed as Long Covid by Telemedicine - A Cautionary Tale. Sawamura T, Karashima S, Kometani M, Ohmori A, Yoneda T. Eur J Case Rep Intern Med. 2024/01
- Performance of Generative Pretrained Transformer on the National Medical Licensing Examination in Japan. Tanaka Y, Nakata T, Aiga K, Etani T, Muramatsu R, Katagiri S, Kawai H, Higashino F, Enomoto M, Noda M, Kometani M, Takamura M, Yoneda T, Kakizaki H, Nomura A. PLOS Digit Health. 2024/01
- A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling. Aiga K, Kometani M, Karashima S, Konishi S, Higashitani T, Aono D, Mai X, Usukura M, Asano T, Wakayama A, Noda Y, Koda W, Minami T, Kobayashi S, Murayama T, Yoneda T. Sci Rep. 2023/12
- Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results. Mizoguchi R, Karashima S, Miyajima Y, Ogura K, Kometani M, Aono D, Konishi S, Demura M, Tsujiguchi H, Hara A, Nakamura H, Yoneda T, Okamoto S, Satou K. Hypertens Res. 2023/10
- Recurrence of Primary Aldosteronism After Surgery in Aldosterone-producing Adenoma With KCNJ5 Gene Mutation. Aiga K, Kometani M, Aono D, Yoneda T. JCEM Case Rep. 2023/01
- Acquisition of Interleukin-6 Production Ability Over Time With Pheochromocytoma. Toyoda Y, Aiga K, Kometani M, Yoneda T. JCEM Case Rep. 2023/09
- Using telemedicine to manage a patient with a hypertensive emergency due to pheochromocytoma. Konishi S, Kometani M, Aiga K, Aono D, Nohara T, Ikeda H, Karashima S, Takeda Y, Yoneda T. Endocrinol Diabetes Metab Case Rep. 2023/07
- In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodies. Asaka H, Karashima S, Chujo D, Kometani M, Usukura M, Yagi K, Aiga K, Yoneda T. Diabetol Int. 2023/06
- Fulminant type 1 diabetes developed after influenza split vaccination. Sawamura T, Karashima S, Ohmori A, Sawada K, Aono D, Kometani M, Takeda Y, Yoneda T. Endocrinol Diabetes Metab Case Rep. 2023/05
- Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1. Takeda Y, Demura M, Kometani M, Karashima S, Yoneda T, Takeda Y Int J Mol Sci 2023/03
- Abnormal findings in the basal ganglia: a diagnostic clue for patients with diabetic striatopathy. Sawamura T, Karashima S, Kawahara H, Yoneda T BMJ Case Rep. 2023/03
- Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism. YKobayashi H, Nakamura Y, Abe M, Tanabe A, Sone M, Katabami T, Kurihara I, Ichijo T, Tsuiki M, Izawa S, Wada N, Yoneda T, Takahashi K, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Rakugi H, Naruse M Endocr J. 2023/02
- A hyperaldosteronism subtypes predictive model using ensemble learning. Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T Sci Rep. 2023/02
- Impact of Conducting Adrenal Venous Sampling in the Morning Versus Afternoon in Primary Aldosteronism. Yoneda M, Kometani M, Aiga K, Karashima S, Usukura M, Mori S, Takeda Y, Aono D, Konishi S, Okumura K, Ogi T, Kobayashi S, Takeda Y, Yoneda T. J Endocr Soc. 2023/01
- Adrenal Hemorrhaging in a Patient with Severe Obstructive Sleep Apnea Syndrome with Elevated Plasma ACTH Levels Sawamura T, Karashima S, Aono D, Ohmori A, Kometani M, Takeda Y, Yoneda T. Intern Med. 2022/12
- Comprehensive Steroid Assay with Non-Targeted Analysis Using Liquid Chromatography Ion Mobility Mass Spectrometry Yamakawa M, Karashima S, Takata R, Haba T, Kuroiwa K, Touyama H, Hashimoto A, Konishi S, Aono D, Kometani M, Nambo H, Yoneda T, Int J Mol Sci. 2022/11
- Mai X, Kometani M, Yoneda T Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review. Mai X, Kometani M, Yoneda T Int J Mol Sci. 2022/11
- Impact of gut microbiome on dyslipidemia in japanese adults: Assessment of the Shika-machi super preventive health examination results for causal inference. Miyajima Y, Karashima S, Ogai K, Taniguchi K, Ogura K, Kawakami M, Nambo H, Kometani M, Aono D, Demura M, Yoneda T, Tsujiguchi H, Hara A, Nakamura H, Okamoto S. Front Cell Infect Microbiol 2022/09
- Hiccups as the first presentation of secondary adrenal insufficiency associated with advanced cervical cancer. Sawamura T, Karashima S, Ohmori A, Sawada K, Aono D, Kometani M, Takeda Y, Yoneda T. Endocrinol Diabetes Metab Case Rep. 2022/08
- A case of adrenocortical carcinoma diagnosed 9 years after the discovery of adrenal incidentaloma. Aono D, Kometani M, Asano T, Konishi S, Karashima S, Ikeda H, Nohara T, Yoneda T. Endocr J. 2022/12
- Effect of Intraprocedural Cortisol Measurement on ACTH-stimulated Adrenal Vein Sampling in Primary Aldosteronism Kometani M, Yoneda T, Karashima S, Takeda Y, Tsuiki M, Yasoda A, Kurihara I, Wada N, Katabami T, Sone M, Ichijo T, Tamura K, Ogawa Y, Kobayashi H, Okamura S, Inagaki N, Kawashima J, Fujita M, Oki K, Matsuda Y, Tanabe A, Naruse M. J Endocr Soc. 2022/09
- The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. Spyroglou A, Handgriff L, Müller L, Schwarzlmüller P, Parasiliti-Caprino M, Fuss CT, Remde H, Hirsch A, O'Toole SM, Thuzar M, Petramala L, Letizia C, Deflorenne E, Amar L, Vrckovnik R, Kocjan T, Zhang CD, Li D, Singh S, Katabami T, Yoneda T, Murakami M, Wada N, Inagaki N, Quinkler M, Ghigo E, Maccario M, Stowasser M, Drake WM, Fassnacht M, Bancos I, Reincke M, Naruse M, Beuschlein F. Eur J Endocrinol. 2022/07
- Evaluating tubulointerstitial compartments in renal biopsy specimens using a deep learning-based approach for classifying normal and abnormal tubules Hara S, Haneda E, Kawakami M, Morita K, Nishioka R, Zoshima T, Kometani M, Yoneda T, Kawano M, Karashima S, Nambo H. PLoS One 2022/07
- Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Nomura M, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Otsuki M, Yabe D, Izawa S, Takahashi Y, Suzuki T, Yasoda A, Tanabe A, Naruse M Hypertens Res 2022/09
- Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome. Nomura C, Nakano Y, Tanaka T, Shima KR, Kometani M, Kanamori T, Ikeda H, Takeshita Y, Yoneda T, Takamura T. Intern Med. 2022/12
- Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Endocr J. 2022/04
- Impact of salt intake on urinary albumin excretion in patients with type 2 diabetic nephropathy: a retrospective cohort study based on a generalized additive model. Kotake Y, Karashima S, Kawakami M, Hara S, Aono D, Konishi S, Kometani M, Mori H, Takeda Y, Yoneda T, Nambo H, Furukawa K. Endocr J. 2022/05
- Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide. Sawamura T, Karashima S, Ohmori A, Sawada K, Kometani M, Takeda Y, Yoneda T. Medicina (Kaunas). 2022/02
- Explainable Machine Learning for Atrial Fibrillation in the General Population Using a Generalized Additive Model - A Cross-Sectional Study. Kawakami M, Karashima S, Morita K, Tada H, Okada H, Aono D, Kometani M, Nomura A, Demura M, Furukawa K, Yoneda T, Nambo H, Kawashiri MA. Circ Rep. 2021/12
- Artificial Intelligence in Current Diabetes Management and Prediction. Nomura A, Noguchi M, Kometani M, Furukawa K, Yoneda T Curr Diab Rep. 2021/12
- Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism. Naruse M, Tanabe A, Yamamoto K, Rakugi H, Kometani M, Yoneda T, Kobayashi H, Abe M, Ohno Y, Inagaki N, Izawa S, Sone M. Endocrinol Metab (Seoul). 2021/10
- Early Detection of Symptom Exacerbation in Patients With SARS-CoV-2 Infection Using the Fitbit Charge 3 (DEXTERITY): Pilot Evaluation. Yamagami K, Nomura A, Kometani M, Shimojima M, Sakata K, Usui S, Furukawa K, Takamura M, Okajima M, Watanabe K, Yoneda T. JMIR Form Res. 2021/09
- Penile and scrotal oedema along with urinary retention after insulin therapy. Takeda Y, Karashima S, Kometani M, Yoneda T. BMJ Case Rep. 2021/07
- Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period. Saito K, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Yamamoto K, Yamada M, Kamemura K, Fujii Y, Suzuki T, Yasoda A, Tanabe A, Naruse M; Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study Group. J Hypertens. 2021/11
- Carcinoma of unknown primary origin with isolated adrenal metastasis: a report of two cases Kometani M, Yoneda T, Maeda Y, Ohtsubo K, Yamazaki Y, Ikeda H, Mori S, Aono D, Karashima S, Usukura M, Sasano H, Takeda Y Endocr J. 2021/10
- DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases. Takeda Y, Demura M, Yoneda T, Takeda Y. Int J Mol Sci. 2021/04
- Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors? Okamoto K, Ohno Y, Sone M, Inagaki N, Ichijo T, Yoneda T, Tsuiki M, Wada N, Oki K, Tamura K, Kobayashi H, Izawa S, Tanabe A, Naruse M. Front Endocrinol (Lausanne). 2021/04
- Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study. Kometani M, Yoneda T, Aono D, Gondoh-Noda Y, Matsuoka T, Higashitani T, Yoshikura S, Sawada K, Takeda Y, Fujimoto A, Karashima S, Usukura M, Takeda Y. Intern Med. 60 7 993-998. 2021/04
- Effect of potassium on DNA methylation of aldosterone synthase gene. Takeda Y, Demura M, Wang F, Karashima S, Yoneda T, Kometani M, Aomo D, Hashimoto A, Horike SI, Meguro-Horike M, Takeda Y. J Hypertens. 2021/04
- Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism. Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Watanabe M, Kamemura K, Okamura S, Tanabe A, Naruse M; JPAS/JRAS Study Group. Sci Rep. 11 1 6925. 2021/03
- Renal Artery Aneurysm Due to Fenestration of a Branch of the Renal Artery: A Case Study. Karashima S, Kometani M, Aono D, Higashitani T, Nishimoto Y, Konishi S, Demura M, Takeda Y, Yoneda T. J Endocr Soc. 30 5 2020/11
- A case of renovascular hypertension with incidental primary bilateral macronodular adrenocortical hyperplasia. Higashitani T, Karashima S, Aono D, Konishi S, Kometani M, Oka R, Demura M, Furukawa K, Yamazaki Y, Sasano H, Yoneda T, Takeda Y. Endocrinol Diabetes Metab Case Rep. 2020 19-0163. 2020/08
- Pheochromocytoma crisis with cyclic fluctuation in blood pressure mimics acute coronary syndrome. Kometani M, Yoneda T, Maeda Y, Oe M, Takeda Y, Higashitani T, Aono D, Yoshino A, Karashima S, Takeda Y. Endocrinol Diabetes Metab Case Rep. 2020 20-0115. 2020/09
- Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism. Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Oki K, Kamemura K, Tanabe A, Naruse M; JPAS/JRAS study group. Hypertension. 77 2 537-545. 2021/02
- Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study. Sawamura T, Karashima S, Nagase S, Nambo H, Shimizu E, Higashitani T, Aono D, Ohbatake A, Kometani M, Demura M, Furukawa K, Takeda Y, Yoneda T. BMC Endocr Disord. 20 1 177 2020/11
- The association of primary aldosteronism with glaucoma-related fundus abnormalities. Ohshima Y, Higashide TSakaguchi K, Sasaki M, Udagawa S, Ohkubo S, Yoneda T, Sugiyama K. PLoS One. 15 11 e0242090. 2020/11
- Impact of Gut Microbiome on Hypertensive Patients With Low-Salt Intake: Shika Study Results. Nagase S, Karashima S, Tsujiguchi H, Tsuboi H, Miyagi S, Kometani M, Aono D, Higashitani T, Demura M, Sakakibara H, Yoshida A, Hara A, Nakamura H, Takeda Y, Nambo H, Yoneda T, Okamoto S. Front Med (Lausanne). 7 475 2020/09
- Feasibility of a Novel Mobile C-Reactive Protein-Testing Device Using Gold-Linked Electrochemical Immunoassay: Clinical Performance Study. Gondoh-Noda Y, Kometani M, Nomura A, Aono D, Karashima S, Ushijima H, Tamiya E, Murayama T, Yoneda T. JMIR Mhealth Uhealth. 8 9 e18782 2020/09
- Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism. Kobayashi Y, Haze T, Yano Y, Tamura K, Kurihara I, Ichijo T, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yamada T, Okamoto R, Fujita M, Kamemura K, Yamamoto K, Izawa S, Tanabe A, Naruse M; JPAS/JRAS Study Group. Kidney Int Rep. 5 8 1291-1297. 2020/06
- Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice. Hashimoto A, Takeda Y, Karashima S, Kometani M, Aono D, Demura M, Higashitani T, Konishi S, Yoneda T, Takeda Y. Hypertens Res. 43 10 1099-1104. 2020/10
- Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism. Ohno Y, Sone M, Inagaki N, Kawashima A, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Ichijo T, Katabami T, Wada N, Sakamoto R, Ogawa Y, Yoshimoto T, Yamada T, Kawashima J, Matsuda Y, Kobayashi H, Kamemura K, Yamamoto K, Otsuki M, Okamura S, Izawa S, Okamoto R, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group. Hypertension. 75 6 1475-1482. 2020/06
Conference Presentations
Others
Arts and Fieldwork
Patent
Theme to the desired joint research
○The role of cardiovacular hormone in the pathogenesis of hypertension
Grant-in-Aid for Scientific Research
○「末端肥大症の成因における遺伝子学的研究」(2001-)
○「AIアプリPHRとVRを活用した３Dオンライン診療システムの構築」(2021-2023)
○「XRを活用した前方視的（リアルタイム）食事指導AIアプリ開発と検証」(2022-2024)
○「原発性アルドステロン症における新治療戦略ー安全かつ高奏功な根本治療の開発」(2022-2025)
○「AIアプリPHRとVRを活用した３Dオンライン診療システムの構築」(2021-2023)
○「原発性アルドステロン症における網膜神経節細胞死―その機序と緑内障との比較―」(2021-2023)
○「生活習慣病における多機能携帯電話を用いた遠隔診療システムの構築」(2017-2019)
○「地域医療における軽症糖尿病患者に対する在宅健康サービスの継続研究」(2013-2015)
○「地域医療における軽症糖尿病患者に対する在宅健康サービスの構築」(2010-2012)
Competitive research funding,Contribution
Collaborative research,Consignment study
Classes (Bachelors)
○Future of Medical Science(2022)
○Cross-cultural Experiences(2022)
○Cross-cultural Experiences(2022)
○Digital transformation in the medical and health care field(2022)
○Introduction to Region-studies(2022)
○Introduction to Region-studies(2022)
○Practicum in Different Cultures I(2022)
○Innovation in Medical and Pharmaceutical Science(2022)
○Pathophysiology 2(2022)
○Pathophysiology 2(2022)
○Oncology(2022)
○Oncology(2022)
○Oncology(2022)
○Oncology(2022)
○Innovation Essence Ⅱ(2021)
○Entrepreneurship I(2021)
○Entrepreneur: Practical Strategy(2021)
○Introduction to Region-studies(2021)
○Introduction to Region-studies(2021)
○Pathophysiology 2(2021)
○Presentation and Debate(2021)
○Academic Skills(2021)
○Innovation & Entrepreneurship II(2020)
○Pathophysiology 2(2020)
○Organ Physiology(2020)
○Introduction to Region-studies(2020)
○Practice of Wellness Promotion(2020)
○Practice of Wellness Promotion(2020)
○Practice of Wellness Promotion(2020)
○Practice of Wellness Promotion(2020)
○Introduction to Region-studies(2019)
○Introduction to Information Technology(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Health Promotion of the Future(2019)
○Freshman Seminar I(2019)
○Practice of Wellness Promotion(2019)
○Presentation and Debate (Freshman Seminar II)(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Health Promotion of the Future(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Health Promotion of the Future(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Practice of Wellness Promotion(2019)
○Medical innovation(2019)
○Pathophysiology 2(2019)
Classes (Graduate Schools)
○Health Promotion and Medicin of the Future(2021)
○Seminar of Medical Innovation(2021)
○Seminar of Medical Innovation(2021)
○Introduction to Health System in JapanⅡ(2021)
○Introduction to Health System in JapanⅠ(2021)
○Seminar on Regulatory Science(2021)
○Preventive Medicine(2021)
○Health Promotion and Medicin of the Future(2020)
○Health Promotion and Medicin of the Future(2020)
○Introduction to Health System in JapanⅡ(2020)
○Introduction to Health System in JapanⅠ(2020)
○Seminar of Medical Innovation(2020)
○Seminar on Regulatory Science(2020)
○Seminar of Medical Innovation(2020)
○Seminar of Medical Innovation(2020)
○Seminar on Regulatory Science(2020)
○Seminar on Medical Innovation(2020)
○Medical Sciences(2020)
○Preventive Medicine(2020)
○Introduction to Health System in JapanⅠ(2019)
○Seminar on Regulatory Science(2019)
○Seminar of Medical Innovation(2019)
○Health Promotion and Medicin of the Future(2019)
○Health Promotion and Medicin of the Future(2019)
○Preventive Medicine(2019)
○Seminar on Regulatory Science(2019)
○Seminar of Medical Innovation(2019)
○Seminar of Medical Innovation(2019)
○Introduction to Health System in JapanⅡ(2019)
○Seminar of Medical Innovation(2017)
○Seminar on Regulatory Science(2017)
○Seminar on Regulatory Science(2017)
○Seminar of Medical Innovation(2017)
○Seminar of Medical Innovation(2017)
○Seminar on Regulatory Science(2016)
○Seminar on Regulatory Science(2016)
○Seminar of Medical Innovation(2016)
○Seminar of Medical Innovation(2016)
○Seminar of Medical Innovation(2016)